{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:08:17Z","timestamp":1783487297692,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ijid.2015.08.011","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T14:59:28Z","timestamp":1440860368000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?"],"prefix":"10.1016","volume":"39","author":[{"given":"B.","family":"Pilmis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Delory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Emirian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lecuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lesprit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-R.","family":"Zahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2015.08.011_bib0165","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/jac\/dkp108","article-title":"Nationwide survey of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in the French community setting","volume":"63","author":"Arpin","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2015.08.011_bib0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","article-title":"Extended-spectrum \u03b2-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy","volume":"39","author":"Meier","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2015.08.011_bib0175","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.diagmicrobio.2011.03.021","article-title":"Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010","volume":"70","author":"Hoban","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2015.08.011_bib0180","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.08.011_bib0185","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1128\/AAC.48.10.3765-3772.2004","article-title":"Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers","volume":"48","author":"Pletz","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.08.011_bib0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe","volume":"18","author":"Cant\u00f3n","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2015.08.011_bib0195","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"168","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijid.2015.08.011_bib0200","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ijid.2015.08.011_bib0205","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/AAC.00135-13","article-title":"Impact of the MIC of piperacillin\u2013tazobactam on the outcome of patients with bacteremia due to extended-spectrum-\u03b2-lactamase-producing Escherichia coli","volume":"57","author":"Retamar","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ijid.2015.08.011_bib0210","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1093\/jac\/dku215","article-title":"The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"69","author":"Park","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2015.08.011_bib0215","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/cid\/cis916","article-title":"Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters","volume":"56","author":"Lee","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.08.011_bib0220","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.46.5.1481-1491.2002","article-title":"Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.08.011_bib0225","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1469-0691.2000.00107.x","article-title":"Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)","volume":"6","author":"Paterson","year":"2000","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2015.08.011_bib0230","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.08.011_bib0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/sur.2009.9930","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"11","author":"Solomkin","year":"2010","journal-title":"Surg Infect"},{"key":"10.1016\/j.ijid.2015.08.011_bib0240","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.08.011_bib0245","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. 1992. Chest 2009; 136(5 Suppl) e28."},{"issue":"RR-03","key":"10.1016\/j.ijid.2015.08.011_bib0250","first-page":"1","article-title":"Revised surveillance case definition for HIV infection\u2014United States, 2014","volume":"63","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ijid.2015.08.011_bib0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajic.2008.01.004","article-title":"Administrative coding data, compared with CDC\/NHSN criteria, are poor indicators of health care-associated infections","volume":"36","author":"Stevenson","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijid.2015.08.011_bib0260","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints, version 01\/01\/2014. Available at: http:\/\/www.eucast.org (accessed March 31, 2014)."},{"key":"10.1016\/j.ijid.2015.08.011_bib0265","first-page":"832","article-title":"[Antibiogram Committee of the French Microbiology Society. Report 2000-2001]","volume":"48","author":"Soussy","year":"2000","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijid.2015.08.011_bib0270","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.08.011_bib0275","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s10096-013-1918-5","article-title":"Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysis","volume":"32","author":"Delory","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2015.08.011_bib0280","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/CCM.0b013e3182416ecf","article-title":"Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?","volume":"40","author":"Heenen","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2015.08.011_bib0285","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccm.2011.05.009","article-title":"De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia?","volume":"32","author":"Niederman","year":"2011","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ijid.2015.08.011_bib0290","article-title":"Elaboration of a consensual definition of de-escalation allowing a ranking of \u03b2-lactams","volume":"21","author":"Weiss","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2015.08.011_bib0295","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00134-007-0619-x","article-title":"De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate","volume":"33","author":"Giantsou","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijid.2015.08.011_bib0300","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.CCM.0000050298.59549.4A","article-title":"Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome","volume":"31","author":"Leone","year":"2003","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.ijid.2015.08.011_bib0305","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin\u2013tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","volume":"60","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.08.011_bib0310","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1086\/510587","article-title":"Direct E-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia","volume":"44","author":"Bouza","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.08.011_bib0315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","article-title":"De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock","volume":"40","author":"Garnacho-Montero","year":"2014","journal-title":"Intensive Care Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971215002064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971215002064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T08:51:26Z","timestamp":1748595086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971215002064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":31,"alternative-id":["S1201971215002064"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2015.08.011","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2015.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}